We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRSL
326
Brightstar Lottery PLC
BRSL
$2.03B
| $19.1M | 0.04% |
715,036
+629,583
| +737% | +$17.5M |
|
327
Teradata
TDC
$2.55B
| $19.1M | 0.04% |
481,209
+370,075
| +333% | +$14.6M |
|
328
Progress Software
PRGS
$1.76B
| $18.9M | 0.04% |
490,411
+217,382
| +80% | +$9.96M |
|
329
Sony
SONY
$138B
| $18.8M | 0.04% |
+1,947,425
| New | +$19.2M |
|
330
TransUnion
TRU
$15.3B
| $18.8M | 0.04% |
331,200
+165,000
| +99% | +$9.52M |
|
331
Grupo Aeroportuario del Pacifico
PAC
$13.3B
| $18.5M | 0.04% |
185,266
+105,229
| +131% | +$10.7M |
|
332
Jones Lang LaSalle
JLL
$16.7B
| $18.4M | 0.04% |
105,343
+13,594
| +15% | +$2.18M |
|
|
WNS
333
DELISTED
WNS Holdings
WNS
| $18.4M | 0.04% |
405,425
-175,315
| -30% | -$7.69M |
|
334
Medifast
MED
$141M
| $18.3M | 0.04% |
196,319
+6,700
| +4% | +$501K |
|
335
Simon Property Group
SPG
$72.3B
| $18.1M | 0.04% |
117,200
+112,600
| +2,448% | +$17.9M |
|
336
Kulicke & Soffa
KLIC
$4.78B
| $18.1M | 0.04% |
722,853
-30,533
| -4% | -$736K |
|
337
Braskem
BAK
$913M
| $18M | 0.04% |
620,866
+75,344
| +14% | +$2.19M |
|
338
Packaging Corp of America
PKG
$22.8B
| $17.9M | 0.04% |
+158,536
| New | +$19.1M |
|
|
INFO
339
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $17.9M | 0.04% |
370,102
-104,129
| -22% | -$4.92M |
|
|
NOAH
340
Noah Holdings
NOAH
$603M
| $17.8M | 0.04% |
377,486
+21,802
| +6% | +$1.05M |
|
|
SKX
341
DELISTED
Skechers
SKX
| $17.7M | 0.04% |
+453,969
| New | +$18.1M |
|
|
MSGN
342
DELISTED
MSG Networks Inc.
MSGN
| $17.6M | 0.04% |
779,401
+325,574
| +72% | +$7.68M |
|
343
Sprouts Farmers Market
SFM
$8.01B
| $17.4M | 0.04% |
740,739
-469,395
| -39% | -$12M |
|
|
TSG
344
DELISTED
The Stars Group Inc.
TSG
| $17.3M | 0.04% |
626,299
+473,199
| +309% | +$12.4M |
|
|
BFYT
345
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $17.2M | 0.04% |
595,312
-72,896
| -11% | -$2.05M |
|
346
HubSpot
HUBS
$10.5B
| $17.1M | 0.04% |
+158,348
| New | +$16.5M |
|
347
Honda
HMC
$41.3B
| $17.1M | 0.04% |
+492,560
| New | +$17.4M |
|
348
Fresenius Medical Care
FMS
$12.9B
| $16.9M | 0.04% |
331,766
+299,866
| +940% | +$16M |
|
349
Compañía de Minas Buenaventura
BVN
$8.67B
| $16.9M | 0.04% |
1,110,808
+893,083
| +410% | +$13.5M |
|
350
ITT
ITT
$19.1B
| $16.9M | 0.04% |
344,227
+279,927
| +435% | +$14.8M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.